Transaction · 0001213900-26-109156
RTSNRetension Pharmaceuticals, Inc.
Bisson Sabine
Bisson Sabine, COO, reported a transaction classified as unknown at Retension Pharmaceuticals, Inc. involving 2504.000000 shares. Reported holdings after the transaction were 4115.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
unknownSEC transaction code CCOO
- Trade date
- Oct 13, 2026
- Filing date
- Oct 13, 2026
How reported position traded is calculated
Calculated only for code-P purchases and code-S sales.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
Filing warnings
Notes recorded with this filingmissing priceThe filing did not provide a usable price per share.
RTSN price since this filing
Daily closing prices, with the filing date and available return windowsRTSN · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago1d ago -2.7%
Returns since7d30d90d180d1y
Transaction facts
Stored Form 4 columns with their raw values
- Type
- unknown Code C
- Identifier
- 0001213900-26-109156 Common Stock
- Transaction date
- Oct 13, 2026 Filed Oct 13, 2026, 10:11 PM · 0d delay
- Shares
- 2,504 sh Price unknown
- Estimated value
- — Computed from shares × price
- Holdings after
- 4,115 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership Large Holdings Increase
Filing-only score
+2 points
Compact filing score computed from stored Form 4 facts. Version v1.
Neutral filing signal
This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 0
Filing reported within two business days of the transaction. - missing_price-8 points
price_cents is null
Missing price reduces confidence in value-based signals.
Missing facts
Read the scoring methodology- price_cents
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Reported roles
CHIEF OPERATING OFFICER
Officer YesDirector No10% NoOther No
Footnotes & amended
- F1
Each share of Series A Convertible Preferred Stock (the "Series A Preferred Stock") converted automatically into one share of Common Stock immediately prior to the closing of the Issuer's initial publ…
- F2
Each share of Series B Convertible Preferred Stock (the "Series B Preferred Stock") converted automatically into one share of Common Stock immediately prior to the closing of the Issuer's initial publ…
Related transactions
Same SEC filing0 other transactions
Recent company activity
RTSN0 recent txs